Breast CancerSABCS Coverage
A research study led by Dr. Paolo Nuciforo at the Vall d’Hebron Institute of Oncology, Molecular Oncology in Barcelona, Spain, supports using pathologic complete response (pCR) to guide early-stage HER2+ breast cancer treatment. The study,…